| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/16/2014 | CN103721255A Application of co-blocking of PD-1 and TIM-3 signal paths to anti-stomach-cancer treatment |
| 04/16/2014 | CN103720699A Application of aspirin in preparing anti-AIDs (Acquired Immune Deficiency Syndrome) drugs |
| 04/16/2014 | CN103720655A D-type polypeptide mediated targeted liposome, preparation method and application thereof |
| 04/16/2014 | CN103041393B Preparation method of nano multi-medicine medicine carrying system for treating cancer |
| 04/16/2014 | CN102885783B Nanometer medicament microspheres |
| 04/16/2014 | CN102847155B Method for inhibiting tumor metastasis |
| 04/16/2014 | CN102746414B Sedimentation method of lipopolysaccharides |
| 04/16/2014 | CN102711746B Pharmaceutical composition for treating alcohol dependency |
| 04/16/2014 | CN102458472B Pharmaceutical composition, food or beverage, and methods for these products |
| 04/16/2014 | CN102458351B Agent for preventing or treating abnormality in skin water permeation function |
| 04/16/2014 | CN101366699B Novel lipid composition aerosol for controlled release of active pharmaceutical ingredient via inhalation |
| 04/15/2014 | US8697738 Alpha-aminoamide derivatives useful in the treatment of addictive disorders |
| 04/15/2014 | US8697717 Inhibitors of histone deacetylase |
| 04/15/2014 | US8697712 Presentation of an antiviral pharmaceutical composition |
| 04/15/2014 | US8697698 Pyrazole compounds useful as protein kinase inhibitors |
| 04/15/2014 | US8697633 Dissolution of arterial plaque |
| 04/15/2014 | US8697158 Mineral amino acid polysaccharide complex |
| 04/15/2014 | US8697138 Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
| 04/15/2014 | US8697137 Methods of using microspheres for active embolization |
| 04/15/2014 | US8697077 Methods and compositions for treating autoimmune diseases |
| 04/15/2014 | US8697069 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells |
| 04/15/2014 | US8697055 Probiotic, lactic acid-producing bacteria |
| 04/15/2014 | US8697053 Compositions and methods for inhibiting pathogenic growth |
| 04/15/2014 | US8697048 Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells |
| 04/15/2014 | CA2615598C Compositions for treatment of systemic mastocytosis |
| 04/15/2014 | CA2547899C Cell-based therapies for ischemia |
| 04/15/2014 | CA2399298C Use of il-18 inhibitors |
| 04/15/2014 | CA2383877C Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 04/15/2014 | CA2328414C Methods for detecting and inhibiting angiogenesis |
| 04/10/2014 | WO2014055415A1 Cancer treatments |
| 04/10/2014 | WO2014054798A1 Drug for inhibiting malignant tumor metastasis |
| 04/10/2014 | WO2014054651A1 Sleep-improving agent, non-rem sleep time-increasing agent, and sedative agent |
| 04/10/2014 | WO2014053852A1 Treatment of cancer |
| 04/10/2014 | WO2014053579A1 A combination of adrenalin with an antidepressant for use in the treatment of shocks |
| 04/10/2014 | WO2014053482A1 Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists |
| 04/10/2014 | WO2014053222A1 Phospholipid drug analogs |
| 04/10/2014 | WO2014022340A3 Therapeutic compostions and methods |
| 04/10/2014 | US20140100289 Methods and compositions for treating mammalian nerve tissue injuries |
| 04/10/2014 | US20140100282 Intranasal administration of pharmaceutical agents for treatment of neurological diseases |
| 04/10/2014 | US20140100271 New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis |
| 04/10/2014 | US20140100270 Radiation countermeasure agents |
| 04/10/2014 | US20140100263 Methods for treatment of alport syndrome |
| 04/10/2014 | US20140100261 Trpm-2 antisense therapy |
| 04/10/2014 | US20140100260 Enalapril Compositions |
| 04/10/2014 | US20140100252 Amorphous ritonavir co-precipitated |
| 04/10/2014 | US20140100249 Therapeutic Treatment |
| 04/10/2014 | US20140100246 Aclidinium for use in improving the quality of sleep in respiratory patents |
| 04/10/2014 | US20140100239 Quinazolinedione derivatives as parp inhibitors |
| 04/10/2014 | US20140100231 Non-nucleoside reverse transcriptase inhibitors |
| 04/10/2014 | US20140100229 Fluoroalkyl-substituted pyrazolopyridines and use thereof |
| 04/10/2014 | US20140100225 Novel compounds, their preparation and their uses |
| 04/10/2014 | US20140100221 1H-Pyrrolo[2,3-b]Pyridine Derivatives |
| 04/10/2014 | US20140100220 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 04/10/2014 | US20140100218 Treatment of Mild and Moderate Alzheimer's Disease |
| 04/10/2014 | US20140100216 Stimulators of incretin hormones secretion, method for preparation and use thereof |
| 04/10/2014 | US20140100214 Heterocyclic compounds and uses thereof |
| 04/10/2014 | US20140100187 Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine |
| 04/10/2014 | US20140100182 Nanogel-Mediated Drug Delivery |
| 04/10/2014 | US20140100180 Topical pharmaceutical composition based on semifluorinated alkanes |
| 04/10/2014 | US20140100166 Methods for the prevention or treatment of heart failure |
| 04/10/2014 | US20140100159 Use of relaxin to restore maternal physiology in pregnancies conveived by assisted reproductive technologies |
| 04/10/2014 | US20140100156 Exendin-4 derivatives as dual glp1/glucagon agonists |
| 04/10/2014 | US20140100155 Combination therapy and kit for the prevention and treatment of cystic fibrosis |
| 04/10/2014 | US20140099392 Phaleria macrocarpa extract, extraction process and its use as cholesteryl ester transferase protein (cetp) inhibitor |
| 04/10/2014 | US20140099387 Compositions and methods for treatment |
| 04/10/2014 | US20140099386 Compositions and applications of carotenoids of improved absorption and bioavailability |
| 04/10/2014 | US20140099376 Sequestered antagonist formulations |
| 04/10/2014 | US20140099375 Methods of therapeutic treatment of eyes |
| 04/10/2014 | US20140099370 Controlled release of biologically active compounds |
| 04/10/2014 | US20140099369 Tamper-resistant oral opioid agonist formulations |
| 04/10/2014 | US20140099343 Ophthalmic Device, and Method of Use Thereof, for Increasing Ocular Boundary Lubrication |
| 04/10/2014 | US20140099336 Methods for Treating Dependence |
| 04/10/2014 | US20140099333 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders |
| 04/10/2014 | US20140099331 Zwitterionic immunomodulators for the teatment of asthma and allergy |
| 04/10/2014 | US20140099330 Method and System for Treating Biological Tissue |
| 04/10/2014 | US20140099329 Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro |
| 04/10/2014 | US20140099319 Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders |
| 04/10/2014 | US20140099316 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists |
| 04/10/2014 | US20140099313 Interleukin-13 binding proteins |
| 04/10/2014 | US20140099308 Novel EGFR-Binding Molecules and Immunoconjugates Thereof |
| 04/10/2014 | US20140099300 Methods for predicting and improving the survival of gastric cancer patients |
| 04/10/2014 | US20140099283 2'-chloro nucleoside analogs for hcv infection |
| 04/10/2014 | US20140099281 Methods of treatment using an aminosterol composition |
| 04/10/2014 | US20140099268 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| 04/10/2014 | US20140099260 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 04/10/2014 | US20140099258 Camptothecin-Binding Moiety Conjugates |
| 04/10/2014 | US20140099254 Combination therapy for inducing immune response to disease |
| 04/09/2014 | EP2716304A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME |
| 04/09/2014 | EP2716303A1 Psychic energizer agent and psychic energizer composition |
| 04/09/2014 | EP2716302A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome |
| 04/09/2014 | EP2714086A1 Polyphenol composition for preventing or treating atherosclerosis |
| 04/09/2014 | EP2714085A1 Anti-inflammatory composition |
| 04/09/2014 | EP2714053A1 Opsonized beta-glucan preparations and methods |
| 04/09/2014 | EP2714045A1 Pharmaceutical antiretroviral composition |
| 04/09/2014 | EP2714042A1 An analgesic pharmaceutical composition for oral administration |
| 04/09/2014 | EP2714040A1 Combinations of serotonin receptor agonists for treatment of movement disorders |
| 04/09/2014 | EP2714039A1 Combination therapy of hsp90 inhibitory compounds with mek inhibitors |
| 04/09/2014 | EP2714038A1 Combination therapy of hsp90 inhibitory compounds with mtor/pi3k inhibitors |
| 04/09/2014 | EP2714028A1 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders |
| 04/09/2014 | EP2714022A1 Combination for treatment of diabetes mellitus |